申请人:Eli Lilly and Company
公开号:US06660739B1
公开(公告)日:2003-12-09
This application relates to a compound of formula I
(or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
本申请涉及公式I的化合物(或其药用可接受的盐),其药物组合物,以及其作为Xa因子抑制剂的用途,以及其制备过程和中间体。